g(m2)-ganglioside and Cat-Diseases

g(m2)-ganglioside has been researched along with Cat-Diseases* in 6 studies

Other Studies

6 other study(ies) available for g(m2)-ganglioside and Cat-Diseases

ArticleYear
In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.
    BMC veterinary research, 2016, Mar-31, Volume: 12

    GM1 and GM2 gangliosidoses are progressive neurodegenerative lysosomal storage diseases resulting from the excessive accumulation of GM1 and GM2 gangliosides in the lysosomes, respectively. The diagnosis of gangliosidosis is carried out based on comprehensive findings using various types of specimens for histological, ultrastructural, biochemical and genetic analyses. Therefore, the partial absence or lack of specimens might have resulted in many undiagnosed cases. The aim of the present study was to establish immunohistochemical and immunofluorescent techniques for the auxiliary diagnosis of canine and feline gangliosidoses, using paraffin-embedded brain specimens stored for a long period.. Using hematoxylin and eosin staining, cytoplasmic accumulation of pale to eosinophilic granular materials in swollen neurons was observed in animals previously diagnosed with GM1 or GM2 gangliosidosis. The immunohistochemical and immunofluorescent techniques developed in this study clearly demonstrated the accumulated material to be either GM1 or GM2 ganglioside.. Immunohistochemical and immunofluorescent techniques using stored paraffin-embedded brain specimens are useful for the retrospective diagnosis of GM1 and GM2 gangliosidoses in dogs and cats.

    Topics: Animals; Brain; Cat Diseases; Cats; Dog Diseases; Dogs; Fluorescent Antibody Technique; G(M1) Ganglioside; G(M2) Ganglioside; Gangliosidoses; Immunohistochemistry; Paraffin Embedding; Reproducibility of Results; Retrospective Studies

2016
Clinical and molecular analysis of GM2 gangliosidosis in two apparent littermate kittens of the Japanese domestic cat.
    Journal of feline medicine and surgery, 2007, Volume: 9, Issue:3

    This case report documents clinical and molecular findings in two littermate kittens of the Japanese domestic cat with GM2 gangliosidosis variant 0. Analysis included detailed physical, magnetic resonance imaging, biochemical, pathological and genetic examinations. At first, these littermate kittens showed typical cerebellar signs at approximately 2 months of age. About 2 months later, they progressively showed other neurological signs and subsequently died at about 7 months of age. Magnetic resonance imaging just before the death showed an enlarged ventricular system, T1 hyperintensity in the internal capsule, and T2 hyperintensity in the white matter of the whole brain. Histological findings suggested a type of lysosomal storage disease. Biochemical studies demonstrated that the kittens were affected with GM2 gangliosidosis variant 0, and a DNA assay finally demonstrated that these animals were homozygous for the mutation, which the authors had identified in a different family of the Japanese domestic cat. The findings in the present cases provide useful information about GM2 gangliosidosis variant 0 in Japanese domestic cats.

    Topics: Animals; Brain; Brain Chemistry; Cat Diseases; Cats; DNA Mutational Analysis; Fatal Outcome; Female; G(M2) Ganglioside; Gangliosidoses, GM2; Genotype; Heterozygote; Japan; Male; Mutation; Pedigree; Sandhoff Disease

2007
GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats.
    The Veterinary record, 2004, Dec-04, Volume: 155, Issue:23

    A five-month-old, female Japanese domestic shorthair cat with proportionate dwarfism developed neurological disorders, including ataxia, decreased postural responses and generalised body and head tremors, at between two and five months of age. Leucocytosis due to lymphocytosis with abnormal cytoplasmic vacuolations was observed. The concentration of G(M2)-ganglioside in its cerebrospinal fluid was markedly higher than in normal cats, and the activities of beta-hexosaminidases A and B in its leucocytes were markedly reduced. On the basis of these biochemical data, the cat was diagnosed antemortem with G(M2)-gangliosidosis variant 0 (Sandhoff-like disease). The neurological signs became more severe and the cat died at 10 months of age. Histopathologically, neurons throughout the central nervous system were distended, and an ultrastructural study revealed membranous cytoplasmic bodies in these distended neurons. The compound which accumulated in the brain was identified as G(M2)-ganglioside, confirming G(M2)-gangliosidosis. A family study revealed that there were probable heterozygous carriers in which the activities of leucocyte beta-hexosaminidases A and B were less than half the normal value. The Sandhoff-like disease observed in this family of Japanese domestic cats is the first occurrence reported in Japan.

    Topics: Animals; Brain; Brain Chemistry; Cat Diseases; Cats; Female; G(M2) Ganglioside; Gangliosidoses, GM2; Genotype; Heterozygote; Japan; Male; Pedigree; Sandhoff Disease

2004
Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside.
    Journal of neurochemistry, 1994, Volume: 62, Issue:5

    Ganglioside analysis and quantitative Golgi studies of the cerebral cortex of cats with ganglioside and nonganglioside lysosomal storage diseases reveal a correlation between the amount of accumulated GM2 ganglioside and the extent of ectopic dendrite growth on cortical pyramidal neurons. This correlation was not observed with any of the other gangliosides assayed for, including GM1 ganglioside. These results suggest a specific role for GM2 ganglioside in the initiation of ectopic neurites on pyramidal cells in vivo and are consistent with the developing hypothesis that different gangliosides have specific roles in different cell types dependent upon the receptor or other effector molecules with which they may interact.

    Topics: Aging; Animals; Carbohydrate Metabolism, Inborn Errors; Cat Diseases; Cats; Cerebral Cortex; Dendrites; G(M2) Ganglioside; Gangliosidoses; Pyramidal Cells; Reference Values

1994
Enzyme replacement in feline GM2 gangliosidosis: catabolic effects of human beta-hexosaminidase A.
    Progress in clinical and biological research, 1982, Volume: 94

    Topics: Animals; beta-N-Acetylhexosaminidases; Brain; Cat Diseases; Cats; Disease Models, Animal; G(M2) Ganglioside; Gangliosidoses; Hexosaminidases; Humans

1982
GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency.
    Science (New York, N.Y.), 1977, May-27, Volume: 196, Issue:4293

    Two kitteens with progressive neurologic disease had increased concentrations of GM2 ganglioside in their cerebral cortex. Examination under the light microscope revealed cytoplasmic vacuolation of neurons and hepatocytes. Transmission and scanning electron microscopy demosntrated cytoplasmic inclusions encompassed by membranes in various central nervous system cell types and in hepatocytes. Beta-D-N-acetyl-hexosaminidase activity was reduced to about 1.0 percent of normal in brain, liver, and cultured skin fibroblasts of the diseased kittens; both major electrophoretic forms, A and B, of the enzyme were deficient. In fibroblasts from the parents of the diseased kittens, this enzyme activity was intermediate between that of affected and normal cats, suggesting an autosomal recessive mode of inheritance of the enzyme defect. Histopahtological and ultrastructural lesions, glycolipid storage, enzyme defect, and pattern of inheritance are similar to those of human GM2 gangliosidosis type 2.

    Topics: Animals; Brain; Cat Diseases; Cats; Female; Fibroblasts; G(M2) Ganglioside; Galactosidases; Gangliosidoses; Genes, Recessive; Hexosaminidases; Humans; Kupffer Cells; Liver; Male; Neurons; Pedigree

1977